Is INSM stock a Buy, Sell, or Hold?

Based on our analysis, INSM is currently a HOLD with moderate confidence. 📊 HOLD: INSM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of INSM stock?

Our analysis estimates the fair value range for INSM to be between $114.59 and $133.23. The current price is $129.41.

What is the analyst price target for INSM?

The average Wall Street analyst price target for INSM is $200.18. This implies a potential upside of 54.7% from current levels.

Insmed (INSM) Stock: Buy, Sell, or Hold?

INSM - Insmed, Inc.

PHARMACEUTICAL PREPARATIONS

$129.41

2.13 (1.67%) ▲

5d: +2.16%

30d: -2.17%

90d: +33.8%

HOLD

MODERATE Confidence

Protect Your INSM Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Oct 29, 2026

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Sep 8, 2026 at $125.41 · last confirmed Sep 8, 2026

Strength: 4.1/10

Get Alerted When INSM Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: INSM shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 10.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$28.10

Based on 7.0% avg growth

INTRINSIC VALUE TODAY

$17.45

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: INSM is currently trading at $129.41, which is considered slightly high relative to its 30-day fair value range of $114.59 to $133.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 161.3) compared to its historical average (260.1). Remarkably, the market is currently pricing in an annual earnings decline of 14.7% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, INSM is showing sideways momentum. The price is approaching resistance at $130.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $200.18 (+54.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY HIGH

Historical Trading Range $114.59 - $133.23

Company Quality Score 54/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 65.2%

Protect Your Profits

Holding INSM? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Mixed technical signals (52/100)
BULLISH: High volume confirmation
BULLISH: Trading 54.7% below Wall St target ($200.18)
NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation

Trading Range Analysis

30-Day Trading Range $114.59 - $133.23

Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $117.15

Resistance Level $130.83

Current Trend Sideways

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 161.32

Wall Street Target $200.18 (+54.7%)

Revenue Growth (YoY) 296.1%

Profit Margin -76.9%

Valuation Discount vs History -14.7% cheaper

PE vs Historical 161.3 vs 260.1 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -14.7% (market-implied from PE analysis)

1-Year Target $116.47 (-10%)

2-Year Target $104.82 (-19%)

3-Year Target $94.34 (-27%)

3-Yr Target (if PE normalizes) (PE: 161→260) $152.11 (+18%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 161.3 to 260.1

Stabilization Target: $208.65 (+61.2%)

PE Expansion Potential: +61.2%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 12, 2026 3:55 AM ET
Data refreshes hourly during market hours. Next update: 4:55 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is INSM showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

William Lewis SELL 10699 shares 2026-04-16

William Lewis SELL 10699 shares 2026-04-06

Roger Adsett SELL 88060 shares 2026-04-01

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for INSM.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
DNLI Denali Therapeutics Inc	STRONG BUY 19 analysts	$36	45 HOLD
RNA Atrium Therapeutics, Inc…	STRONG BUY 15 analysts	$25	55 HOLD
INCY Incyte Corporation	HOLD 27 analysts	$127	50 HOLD
JSPR Jasper Therapeutics Inc	STRONG BUY 11 analysts	$7	62 BUY
RLAY Relay Therapeutics Inc	STRONG BUY 13 analysts	$27	64 BUY

DNLI Denali Therapeuti…

45 HOLD

RNA Atrium Therapeuti…

55 HOLD

INCY Incyte Corporation

50 HOLD

JSPR Jasper Therapeuti…

62 BUY

RLAY Relay Therapeutic…

64 BUY

Advanced INSM Option Strategies

Professional options setups generated by AI based on today's INSM price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for INSM

INSM Technical Chart INSM Price Prediction INSM Earnings Date INSM Investment Advisor INSM Fair Price Analyzer INSM Options Advisor INSM Options Chain INSM Options Analysis INSM Competitors

Compare INSM with Peers

INSM vs CYTK
Which one to buy?

INSM vs ALNY
Which one to buy?

INSM vs NTRA
Which one to buy?

INSM vs RARE
Which one to buy?

INSM vs PTCT
Which one to buy?

ABVC vs INSM

VRTX vs INSM
Winner: VRTX

INSM vs ASND

CYTK vs INSM

INSM vs INCY
Winner: INCY

Create New Comparison View All Competitors

Tradestie